Literature DB >> 25952367

Cognitive and affective benefits of combination therapy with galantamine plus cognitive rehabilitation for Alzheimer's disease.

Ryo Tokuchi1,2, Nozomi Hishikawa1, Kosuke Matsuzono1, Yoshiki Takao3, Yosuke Wakutani3, Kota Sato1, Syoichiro Kono1, Yasuyuki Ohta1, Kentaro Deguchi1, Toru Yamashita1, Koji Abe1.   

Abstract

AIM: The aim of the present study was to compare the effects of a galantamine only therapy and a combination therapy with galantamine plus ambulatory cognitive rehabilitation for Alzheimer's disease patients.
METHODS: For this retrospective cohort study, we enrolled 86 patients with Alzheimer's disease, dividing them into two groups - a galantamine only group (group G, n = 45) and a combination with galantamine plus ambulatory rehabilitation group (group G + R, n = 41). The present cognitive rehabilitation included a set of physical therapy, occupational therapy and speech therapy for 1-2 h once or twice a week. We compared the Mini-Mental State Examination and Frontal Assessment Battery for cognitive assessment, and Geriatric Depression Scale, Apathy Scale, and Abe's Behavioral and Psychological Symptoms of Dementia score for affective assessment in two groups over 6 months.
RESULTS: The baseline Mini-Mental State Examination score was 20.2 and 18.7 in groups G and G + R, respectively. Other baseline data (Frontal Assessment Battery, Geriatric Depression Scale, Apathy Scale, and Abe's Behavioral and Psychological Symptoms of Dementia) were not different between the two groups. Although group G kept all the scores stable until 6 months of the treatment, the Apathy Scale score showed a significant improvement in group G + R as early as 3 months, followed by the Mini-Mental State Examination and Frontal Assessment Battery improvements at 6 months (*P = 0.04 and *P = 0.02, respectively). The Geriatric Depression Scale and Abe's Behavioral and Psychological Symptoms of Dementia did not show any changes.
CONCLUSION: The combination therapy of galantamine plus ambulatory cognitive rehabilitation showed a superior benefit both on cognitive and affective functions than galantamine only therapy in Alzheimer's disease patients.
© 2015 Japan Geriatrics Society.

Entities:  

Keywords:  Alzheimer's disease; affective function; cognitive function; combination therapy; galantamine

Mesh:

Substances:

Year:  2015        PMID: 25952367     DOI: 10.1111/ggi.12488

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  3 in total

Review 1.  Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments.

Authors:  Fleur Harrison; Liesbeth Aerts; Henry Brodaty
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

2.  Pharmacological aspects of galantamine for the treatment of Alzheimer's disease.

Authors:  Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2017-01-10       Impact factor: 4.068

3.  Use of Complementary Alternative Medicine and the Associated Factors among Patients with Depression.

Authors:  Hamide Ashraf; Alireza Salehi; Malihe Sousani; Mohammad Hossein Sharifi
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-26       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.